Sustained Endothelial Progenitor Cell Dysfunction After Chronic Hypoxia-Induced Pulmonary Hypertension
Glenn Marsboom(Johnson & Johnson (United States)), Stefan Janssens(Maastricht University), Hilde Gillijns(Ghent University), D Collen(VIB-KU Leuven Center for Cancer Biology), Xiaoshun Liu(Vlaams Instituut voor Biotechnologie), Pieter Vermeersch(Universitair Ziekenhuis Leuven), Olivier Gheysens(Cliniques Universitaires Saint-Luc), Marijke Pellens(Ghent University), Péter Pokreisz(Ghent University)
Cited by 86
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer
|The FASEB Journal|2012|606